Multiple sclerosis after infectious mononucleosis

被引:135
作者
Nielsen, Trine Rasmussen
Rostgaard, Klaus
Nielsen, Nete Munk
Koch-Henriksen, Nils
Haahr, Sven
Sorensen, Per Soelberg
Hjalgrim, Henrik
机构
[1] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark
[2] Aalborg Hosp, Natl Publ Hlth Inst, Aalborg, Denmark
[3] Aalborg Hosp, Dept Neurol, Aalborg, Denmark
[4] Univ Aarhus, Dept Med Microbiol & Immunol, DK-8000 Aarhus C, Denmark
[5] Copenhagen Univ Hosp, Danish Multiple Sclerosis Res Ctr, Dept Neurol, Copenhagen, Denmark
关键词
D O I
10.1001/archneur.64.1.72
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Infectious mononucleosis caused by the Epstein-Barr virus has been associated with increased risk of multiple sclerosis. However, little is known about the characteristics of this association. Objective: To assess the significance of sex, age at and time since infectious mononucleosis, and attained age to the risk of developing multiple sclerosis after infectious mononucleosis. Design: Cohort study using persons tested serologically for infectious mononucleosis at Statens Serum Institut, the Danish Civil Registration System, the Danish National Hospital Discharge Register, and the Danish Multiple Sclerosis Registry. Setting: Statens Serum Institut. Patients: A cohort of 25 234 Danish patients with mononucleosis was followed up for the occurrence of multiple sclerosis beginning on April 1, 1968, or January 1 of the year after the diagnosis of mononucleosis or after a negative Paul-Bunnell test result, respectively, whichever came later and ending on the date of multiple sclerosis diagnosis, death, emigration, or December 31, 1996, whichever came first. Main Outcome Measure: The ratio of observed to expected multiple sclerosis cases in the cohort (standardized incidence ratio). Results: A total of 104 cases of multiple sclerosis were observed during 556 703 person-years of follow-up, corresponding to a standardized incidence ratio of 2.27 (95% confidence interval, 1.87-2.75). The risk of multiple sclerosis was persistently increased for more than 30 years after infectious mononucleosis and uniformly distributed across all investigated strata of sex and age. The relative risk of multiple sclerosis did not vary by presumed severity of infectious mononucleosis. Conclusions: The risk of multiple sclerosis is increased in persons with prior infectious mononucleosis, regardless of sex, age, and time since infectious mononucleosis or severity of infection. The risk of multiple sclerosis may be increased soon after infectious mononucleosis and persists for at least 30 years after the infection.
引用
收藏
页码:72 / 75
页数:4
相关论文
共 27 条
[1]  
Andersen TF, 1999, DAN MED BULL, V46, P263
[2]   Epstein-Barr virus antibodies and risk of multiple sclerosis -: A prospective study [J].
Ascherio, A ;
Munger, KL ;
Lennette, ET ;
Spiegelman, D ;
Hernán, MA ;
Olek, MJ ;
Hankinson, SE ;
Hunter, DJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (24) :3083-3088
[3]   Childhood infections and risk of multiple sclerosis [J].
Bager, P ;
Nielsen, NM ;
Bihrmann, K ;
Frisch, M ;
Hjalgrim, H ;
Wohlfart, J ;
Koch-Henriksen, N ;
Melbye, M ;
Westergaard, T .
BRAIN, 2004, 127 :2491-2497
[4]   Evaluation of 12 commercial tests for detection of Epstein-Barr virus-specific and heterophile antibodies [J].
Bruu, AL ;
Hjetland, R ;
Holter, E ;
Mortensen, L ;
Natås, O ;
Petterson, W ;
Skar, AG ;
Skarpaas, T ;
Tjade, T ;
Åsjo, B .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2000, 7 (03) :451-456
[5]   Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis [J].
Cepok, S ;
Zhou, D ;
Srivastava, R ;
Nessler, S ;
Stei, S ;
Büssow, K ;
Sommer, N ;
Hemmer, B .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (05) :1352-1360
[6]  
CLAYTON D, 1993, STAT METHODS EPIDEMI
[7]  
Esbjerg S, 1999, STAT MED, V18, P1691, DOI 10.1002/(SICI)1097-0258(19990715)18:13<1691::AID-SIM160>3.0.CO
[8]  
2-D
[9]   PROSPECTIVE EVALUATION OF HETEROPHILE AND EPSTEIN-BARR VIRUS-SPECIFIC IGM-ANTIBODY TESTS IN CLINICAL AND SUBCLINICAL INFECTIOUS-MONONUCLEOSIS - SPECIFICITY AND SENSITIVITY OF TESTS AND PERSISTENCE OF ANTIBODY [J].
EVANS, AS ;
NIEDERMAN, JC ;
CENABRE, LC ;
WEST, B ;
RICHARDS, VA .
JOURNAL OF INFECTIOUS DISEASES, 1975, 132 (05) :546-554
[10]  
EVANS AS, 1997, EPIDEMIOLOGY CONTROL